NCT00827411 - Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy | Biotech Hunter

Enrollment

2,500

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

January 31, 2013

Conditions

Coronary Artery DiseaseAcute Coronary Syndrome

Interventions

DRUG

Aspirin and clopidogrel / Prasugrel

modification of aspirin and clopidogrel/Prasugrel maintenance doses based on a biological assay

DEVICE

VerifyNow

point of care assay VerifyNow (ACCUMETRICS San Diego USA)

DRUG

Aspirin and clopidogrel / Prasugrel

aspirin and clopidogrel/ Prasugrel maintenance doses (according to international guidelines)

DRUG

Aspirin and clopidogrel / Prasugrel

maintenance dose of clopidogrel / Prasugrel and aspirin

DRUG

Aspirin

Interruption of clopidogrel / Prasugrel after one year of follow-up

Trial Locations (1)

Institut de Cardiologie- Hopital la Pitié Salpétrière, Paris